Five things for pharma marketers to know: Friday, January 19, 2018

manostaxx3

http://www.manostaxx.com

1. Biogen, UCB, and Asian drugmakers are reportedly interested in acquiring Acorda Therapeutics.CEO Ron Cohen said its levodopa drug CVT-301 for Parkinson’s disease has a market potential of up to $800 million. (Endpoints News)

2. Gilead subsidiary Kite Pharma is teaming up with Pfizer to develop a combo therapy for lymphoma, which includes Kite’s CAR-T therapy Yescarta and Pfizer’s experimental drug utomilumab. Gilead acquired Kite for $11.9 billion last year. (Endpoints News)

3. About 300 hospitals owned by Intermountain Healthcare, Ascension, and other large hospital systems plan to form a nonprofit generics company to combat drug shortages and high prices.(NYT)

4. The House Energy and Commerce Committee advanced a bill this week that would implement a new FDA user-fee program for over-the-counter drugs for the first time in more than 40 years.(Politico)

5. The FDA will issue stricter draft guidance in March on the substances that can be distributed at hospitals and physician’s clinics without prescriptions, said Commissioner Scott Gottlieb. (Reuters)

Continue at: https://www.mmm-online.com/roundup/pharma-acor-biog-ucb-acquisition-gild-pfe-car-t-generics-fda-otc/article/737952/

The text above is owned by the site above referred.

Here is only a small part of the article, for more please follow the link

Also see:

https://dadoswebaxx.weebly.com/

DadosWebaxx

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s